• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RMT231214
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 12/12/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Concomitant medical products: additional device: pxc121000, lot # 10664340, udi: (b)(4).A review of the manufacturing records for the device verified the lot met all pre-release specifications.A review of the sterilization records for the device verified the lot met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to infections.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2013 a patient was undergoing treatment of an abdominal aortic aneurysm with gore® excluder® aaa endoprostheses.On (b)(6) 2017 the patient had a deep sternal wound infection.On (b)(6) 2017 the patient was treated with iv antibiotics, sternal wound debridement and bilateral pectoralis major muscle flap reconstruction.On (b)(6) 2018 the patient reportedly had a right groin pseudoaneurysm with infected ptfe grafts.On (b)(6) 2018 the patient underwent external iliac to mid ptfe graft bypass; triple ligation of femoral vessels and closure of the pseudoaneurysm.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8492761
Report Number3007284313-2019-00095
Device Sequence Number1784054
Product Code MIH
UDI-Device Identifier00733132610518
UDI-Public00733132610518
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Reporter Type Manufacturer
Report Source study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2015
Device Catalogue NumberRMT231214
Device Lot Number10590735
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date04/08/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other; Required Intervention;
Patient Age68 YR
Patient Weight86
-
-